Journal of Clinical Virology
Volume 46, Issue 1 , Pages 24-28 , September 2009

Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate

References 

  1. Caserta MT, Mock DJ, Dewhurst S. Human herpesvirus 6. Clin Infect Dis. 2001;33:829–833
  2. De Bolle L, Naesens L, de Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev. 2005;18:217–245
  3. Portolani M, Pecorari M, Tamassia MG, Gennai W, Beretti F, Guaraldi G. Case of fatal encephalitis by HHV-6 variant A. J Med Virol. 2001;65:133–137
  4. Zerr DM. Human herpesvirus 6: a clinical update. Herpes. 2006;13:20–24
  5. Zerr DM, Gooley TA, Yeung L, Huang ML, Carpenter P, Wade JC, et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis. 2001;33:763–771
  6. Isaacson E, Glaser CA, Forghani B, Amad Z, Wallace M, Armstrong RW, et al. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis. 2005;40:890–893
  7. Tavakoli NP, Nattanmai S, Hull R, Fusco H, Dzigua L, Wang H, et al. Detection and typing of human herpesvirus 6 by molecular methods in specimens from patients diagnosed with encephalitis or meningitis. J Clin Microbiol. 2007;45:3972–3978
  8. Cermelli C, Berti R, Soldan SS, Mayne M, D’ambrosia JM, Ludwin SK, et al. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis. 2003;187:1377–1387
  9. Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A, et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology. 2003;61:1405–1411
  10. Birnbaum T, Padovan CS, Sporer B, Rupprecht TA, Ausserer H, Jaeger G, et al. Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir. Clin Infect Dis. 2005;40:887–889
  11. Harma M, Loginov R, Piiparinen H, Halme L, Hockerstedt K, Lautenschlager I. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplant Proc. 2005;37:1230–1232
  12. Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJG, Marschall M. The antiviral activities of artemisinin and artesunate. Clin Infect Dis. 2008;47:804–811
  13. Adjuik M, Babiker A, Garner P, Olliato P, Taylor W, White N. International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004;363:9–17
  14. Ribeiro IR, Olliaro P. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med Trop. 1998;58:50–53
  15. De Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs. 1996;52:818–836
  16. Gomes M, Ribeiro I, Warsame M, Karunajeewa H, Petzold M. Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies. BMC Infect Dis. 2008;8:39
  17. Efferth T, Marschall M, Wang X, Huong SM, Hauber I, Olbrich A, et al. Antiviral activity of artesunate towards wild-type, recombinant and ganciclovir-resistant human cytomegaloviruses. J Mol Med. 2002;80:233–242
  18. Kaptein JF, Efferth T, Leis M, Rechter S, Auerochs S, Kalmer M, et al. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Antiviral Res. 2006;69:60–69
  19. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001;18:767–773
  20. Efferth T, Benakis A, Romero-Rodriguez M, Steinbach D, Häfer R, Stamminger T, et al. Enhancement of cytotoxicity of artemisinins towards cancer cells by ferrous iron. Free Radicals Biol Med. 2004;37:998–1009
  21. Milbradt J, Auerochs S, Marschall M. Cytomegaloviral proteins pUL50 and pUL53 are associated with the nuclear lamina and interact with cellular protein kinase C. J Gen Virol. 2007;88:2642–2650
  22. Aberle SW, Puchhammer-Stöckl E. Diagnosis of herpesvirus infections of the central nervous system. J Clin Virol. 2002;25:79–85
  23. Yoshikawa T, Asano Y, Akimoto S, Ozaki T, Iwasaki T, Kurata T, et al. Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol. 2002;66:497–505
  24. Crumpacker CS. Ganciclovir. N Engl J Med. 1996;335:721–729
  25. Bork PM, Schmitz LM, Kuhnt M, Escher C, Heinrich M. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-κB. FEBS Lett. 1997;402:85–90
  26. Siedle B, Garcia-Pineres AJ, Murillo R, Schulte-Mönting J, Castro V, Rüngeler P, et al. Quantitative structure–activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-κB. J Med Chem. 2004;47:6042–6054
  27. Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, et al. Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol. 2003;64:382–394
  28. Wagner S, Hofmann A, Siedle B, Terfloth L, Merfort I, Gasteiger J. Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks. J Med Chem. 2006;49:2241–2252
  29. McGready R, Ashley EA, Moo E, Cho T, Barends M, Hutagalung R, et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis. 2005;192:846–853
  30. Gordi T, Lepist EI. Artemisinin derivatives: toxic for laboratory animals, safe for humans?. Toxicol Lett. 2004;147:99–107
  31. Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, et al. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008;46:1455–1457
  32. Schmidt B, Ashlock B, Neipel F, Levy JA. Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon production. J Clin Microbiol. 2004;42:4300–4302
  33. Iyengar S, Levine PH, Ablashi D, Neequaye J, Person GR. Sero-epidemiological investigations on human herpesvirus 6 (HHV-6) infections using a newly developed early antigen assay. Int J Cancer. 1991;49:551–557

PII: S1386-6532(09)00196-6

doi: 10.1016/j.jcv.2009.05.017

Journal of Clinical Virology
Volume 46, Issue 1 , Pages 24-28 , September 2009

Article Tools

* Image Usage & Resolution